WHO vaccine-preventable diseases: monitoring system. 2013 global summary

Last updated 20-Octl-2013 (data as of 16-Oct-2013)
Next overall update June 2014
EPI mother and child logo         
Select a country

Development status: Least developed GNI / capita (US$): 2401 Infant (under 12 months) mortality rate: 862
GDP / capita (US$): 5601 Child (under 5 years) mortality rate: 1392

Population data in thousands3

  2012  2011  2010  2009  2008  2000  1990  1980 
Total population 9'850  9'540  9'233  8'927  8'624  6'674  5'606  4'127 
Births 443  431  417  403  388  288  277  210 
Surviving infants 405  393  380  366  352  258  245  185 
Pop. less than 5 years 1'838  1'769  1'685  1'616  1'545  1'197  1'135  782 
Pop. less than 15 years 4'370  4'213  4'056  3'936  3'822  3'269  2'682  1'831 
Female 15-49 years 2'353  2'287  2'221  2'140  2'058  1'447  1'234  974 

Number of reported case

(Click for retrospective incidence data for Burundi)
Diphtheria
Japanese encephalitis
Measles 49  129  495  305  173  18'363  13'282  49'227 
Mumps
Pertussis 72  529  9'613 
Polio* 10  43 
Rubella 11  67  247  305  173 
Rubella (CRS)
Tetanus (neonatal) 11  16  25 
Tetanus (total) 11  33  65  256 
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Burundi)
Vaccine year result method % card seen                                                
BCG 2009  99  DHS   61.9  98  90  93  98  99  73  97 
DTP1 2009  99  DHS   61.9  98  99*  99  99*  99*  74 
DTP3 2009  95  DHS   61.9  96  99*  96  99*  92  68  86 
HepB_BD         
HepB3 2009  95  DHS   61.9  96  99*  96  99*  92 
Hib3 2009  95  DHS   61.9  96  99*  96  99*  92 
JapEnc         
MCV 2009  94  DHS   61.9  93  99*  92  91  84  61  74 
MCV2         
PCV1          99*  31 
PCV3          99*  14 
Pol3 2009  87  DHS   61.9  96  99*  94  96  89  69  97 
Rota1         
Rota_last         
Rubella1         
TT2plus 2009  32  DHS   61.9  88  99*  94  88  82  28  56 
PAB         
VAD1          27  72  89  67 
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: July 2014

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Burundi)
BCG 98  90  93  98  99  85  97 
DTP1 99  99  99  99  98  88  95 
DTP3 96  96  96  94  92  80  86 
HepB3 96  96  96  94  92 
Hib3 96  96  96  94  92 
MCV 93  93  92  91  84  72  74 
PAB 85  80  94  94  78  51  67 
PCV3 96  14 
Pol3 94  94  94  96  89  71  97 
Rota_last
YFV

Number of districts in the country 45  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 80
From 80 to 89% 13
From 50 to 79% 7
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2012 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwPHibHepB 6, 10, 14 weeks; Yes
Measles 9, 18 months; Yes
OPV birth; 6, 10, 14 weeks; Yes
Pneumo_conj 6, 10, 14 weeks; Yes
Rotavirus 6, 14 weeks; Yes From December 2013
TT 1st contact; +1, +6 months; +1, +1 year; Yes
VitaminA Yes 6-59 months

Immunizaton indicators

Indicator Expected answer 2012  2011  2010  2009  2008  2007  2006 

Planning and management

Multi-year plan (MYP) for immunization Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2011-2015  2011-2015  2010-2014  2010-2014  2006 - 2010  2007-2011  2002-2006 
Nº of districts with microplans that include activities to raise immunization coverage number 45  45  45  45  12  17  17 

National Immunization Advisory Mechanism

Does the country have a standing technical advisory group on immunization? Yes/No/NR No  No  No         

System performance

Total number of districts in country number 45  45  45  43  41  17  17 
Nº districts with DTP3 coverage >=80% number 42  44  41  39  30  16  12 
% of districts with DTP3 coverage >=80% From 0 to 100% 93  98  91  91  73  94  71 
Nº districts with measles (MCV1) coverage >=95% number 31  29  16  24  11     
% of districts with MCV1 coverage >=95% From 0 to 100% 69  64  36  56  27     

Safety

Monitoring of Adverse Events Following Immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
Does your country have a vaccine adverse events review committee? Yes/No/NR/ND No  No  No         

Finance

Percentage of routine vaccines funded by Government From 0 to 100%   NA 

Maternal and neonatal tetanus (NT) elimination

NT eliminated Yes/No Yes  Yes  Yes  Yes  No  No  No 

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2012, data for 2011
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.